Entering Brazil’s pharmaceutical market requires careful planning and regulatory alignment. From ANVISA requirements and product registration to GMP compliance, Portuguese labeling, and post-market obligations, each step is essential. Understanding local regulations early helps companies navigate approval pathways, minimize delays, and prepare pharmaceutical products for successful market entry in Brazil.
